Monthly increments of length, weight gain, and head circumference were recorded from birth to 4 years of age in 52 children with cystic fibrosis. At birth the children showed stunting. Standard deviation (SD) scores at birth for height, weight, and head circumference were -1-24, -0-72, and -1-82 respectively. Over the first four years, length and weight SD scores showed a consistent improvement. However, there was very limited improvement in head circumference, which stabilised 1 SD below the mean from 1.5 years to 4 years. Our data suggest that head growth lags behind gain in height and weight in children with cystic fibrosis despite good nutritional management in early infancy. The data may also support the expression of cystic fibrosis transmembrane conductance regulator in choroid plexus and ependyma. (Arch Dis Child 1995; 72: 150-152) 
Before the mid 1970s, growth failure was considered inevitable in cystic fibrosis. However, by adopting an aggressive nutritional figure. Mean length, weight, and OFC SD scores were all significantly low at birth compared with the population mean (-1*24, p<0 0001, -0-72, p<0 05; and -1-82, p<0-0001 respectively). The length SD score showed a significant improvement from -1 24 at birth to -0 15 at 4 years (p<0-001). Weight SD score also improved significantly from -1-37 at 6 months to -0 53 at 4 years (p<0005). In contrast to the gains in height and weight, the OFC SD score reached a plateau of -1 from 1 5 to 4 years and remained significantly low throughout the four years of measurement (-1-05, p<0 000I at 4 years).
Discussion
There are relatively few recent data on growth patterns in patients with cystic fibrosis in childhood. Older reports precede the introduction of high energy diets and more potent pancreatic enzyme supplements. The detailed Disproportionate head growth retardation in cystic fibrosis Mean SD scores for height, weight, and OFC in children with cystic fibrosis are given grouped according to age. Values for both sexes were pooled together; values for Student's t test are given, based on an expected mean value ofzero In recent years, postnatal screening has been introduced in Trent, although follow up is too brief for all but the earliest diagnosed patients to be included in this study. The effects of early diagnosis and treatment on head growth will be of interest as little benefit from postnatal screening programmes has been demonstrated except for a reduction in hospital admissions in the first year of life. '7 This study suggests that, in cystic fibrosis, despite early diagnosis and careful attention to nutrition, head growth lags behind the rest of the body. Intelligence in children with cystic fibrosis appears to be normally distributed, but evidence is limited.'8 Furthermore, the issue of intellectual performance testing remains controversial.9 18 Expression of the cystic fibrosis gene product, the cystic fibrosis transmembrane conductance regulator (CFTR) has also been reported in brain,'9 20 although its significance is unclear. It is possible that CFTR influences cerebrospinal fluid secretion. This may be deficient in cystic fibrosis, leading to a reduction in brain volume. Studies using magnetic resonance to calculate ventricular volume may throw further light on this matter. cystic fibrosis. 
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